Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jeffrey Swigris

Concepts (372)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Idiopathic Pulmonary Fibrosis
67
2025
692
11.700
 Why?
Lung Diseases, Interstitial
63
2026
664
10.740
 Why?
Quality of Life
47
2025
3204
5.930
 Why?
Dyspnea
28
2025
250
5.730
 Why?
Pulmonary Fibrosis
26
2025
395
5.460
 Why?
Cough
10
2024
124
3.540
 Why?
Oxygen Inhalation Therapy
13
2021
181
3.300
 Why?
Surveys and Questionnaires
38
2025
6066
2.840
 Why?
Vital Capacity
33
2025
292
2.820
 Why?
Connective Tissue Diseases
13
2019
85
2.250
 Why?
Alveolitis, Extrinsic Allergic
6
2024
93
1.840
 Why?
Arthritis, Rheumatoid
13
2026
1180
1.820
 Why?
Lymphangioleiomyomatosis
6
2024
37
1.710
 Why?
Pyridones
12
2023
209
1.620
 Why?
Patient Reported Outcome Measures
7
2024
497
1.480
 Why?
Anti-Inflammatory Agents, Non-Steroidal
11
2021
345
1.460
 Why?
Patient Outcome Assessment
3
2021
130
1.390
 Why?
Severity of Illness Index
20
2025
2930
1.340
 Why?
Indoles
6
2024
507
1.340
 Why?
Sarcoidosis
5
2021
163
1.340
 Why?
Humans
167
2026
145475
1.260
 Why?
Pulmonary Medicine
3
2022
78
1.200
 Why?
Lung
21
2024
4106
1.200
 Why?
Aged
70
2025
26153
1.200
 Why?
Middle Aged
82
2025
36215
1.180
 Why?
Fatigue
9
2024
364
1.150
 Why?
Walking
7
2013
542
1.090
 Why?
Respiratory Function Tests
19
2025
544
1.080
 Why?
Oxygen
7
2023
978
0.990
 Why?
Psychometrics
10
2022
731
0.980
 Why?
Patients
3
2018
183
0.960
 Why?
Tomography, X-Ray Computed
20
2025
2769
0.940
 Why?
Hypertension, Pulmonary
6
2023
1957
0.930
 Why?
Male
91
2025
72843
0.930
 Why?
Exercise Test
9
2024
630
0.910
 Why?
Research Design
5
2016
1137
0.900
 Why?
Health Care Costs
3
2018
425
0.900
 Why?
Female
94
2025
78845
0.900
 Why?
Health Status Indicators
4
2014
167
0.890
 Why?
Patient-Centered Care
2
2021
547
0.860
 Why?
Activities of Daily Living
6
2022
444
0.840
 Why?
Disease Progression
20
2025
2864
0.840
 Why?
Reproducibility of Results
18
2024
3413
0.810
 Why?
Exercise Tolerance
4
2020
283
0.790
 Why?
Mycophenolic Acid
4
2016
120
0.730
 Why?
Forced Expiratory Volume
12
2023
450
0.710
 Why?
Idiopathic Interstitial Pneumonias
7
2026
44
0.690
 Why?
Organizational Objectives
1
2021
67
0.680
 Why?
Internet
2
2016
689
0.670
 Why?
Autoimmune Diseases
5
2026
468
0.660
 Why?
Nursing Research
1
2021
49
0.660
 Why?
Patient Satisfaction
3
2021
709
0.660
 Why?
Caregivers
4
2019
1073
0.650
 Why?
Pulmonary Emphysema
2
2024
277
0.630
 Why?
Lactic Acid
1
2022
295
0.620
 Why?
Rhinitis, Allergic
1
2020
42
0.600
 Why?
Chronic Disease
5
2022
1808
0.600
 Why?
Undifferentiated Connective Tissue Diseases
1
2019
1
0.600
 Why?
Symptom Assessment
1
2020
136
0.600
 Why?
Pulmonary Disease, Chronic Obstructive
4
2022
919
0.580
 Why?
Fatty Acids
1
2022
457
0.550
 Why?
Emphysema
1
2018
100
0.530
 Why?
Particulate Matter
1
2020
326
0.500
 Why?
Patient Education as Topic
3
2019
777
0.500
 Why?
Needs Assessment
2
2019
402
0.490
 Why?
Longitudinal Studies
9
2020
2953
0.490
 Why?
Lung Diseases
3
2015
780
0.490
 Why?
Pulmonary Diffusing Capacity
7
2019
78
0.480
 Why?
Aged, 80 and over
19
2021
8333
0.470
 Why?
Heart Rate
2
2011
855
0.470
 Why?
Immunosuppressive Agents
4
2016
838
0.460
 Why?
Lung Transplantation
1
2019
332
0.450
 Why?
Qualitative Research
4
2017
1674
0.450
 Why?
Air Pollutants
1
2020
405
0.450
 Why?
Prognosis
16
2026
4316
0.450
 Why?
Information Seeking Behavior
1
2016
40
0.450
 Why?
United States
25
2024
16098
0.450
 Why?
Treatment Outcome
20
2023
11772
0.450
 Why?
Myositis
4
2025
57
0.450
 Why?
Gastroesophageal Reflux
2
2021
237
0.440
 Why?
Exercise
4
2022
2198
0.430
 Why?
Adult
39
2024
40777
0.430
 Why?
Narration
1
2016
79
0.430
 Why?
Double-Blind Method
10
2024
2062
0.420
 Why?
Ambulatory Care
2
2018
609
0.420
 Why?
Mental Health
2
2020
793
0.410
 Why?
Kaplan-Meier Estimate
8
2018
969
0.410
 Why?
Retrospective Studies
27
2025
17291
0.400
 Why?
Autoantibodies
6
2023
1509
0.400
 Why?
Autoimmunity
2
2019
933
0.400
 Why?
Telemedicine
1
2023
961
0.400
 Why?
Antibodies, Monoclonal
1
2021
1505
0.390
 Why?
Biomedical Research
2
2018
717
0.390
 Why?
Antitussive Agents
1
2013
7
0.390
 Why?
Bronchiolitis Obliterans
1
2013
61
0.380
 Why?
Thalidomide
1
2013
43
0.380
 Why?
Social Media
1
2016
166
0.370
 Why?
Lung Neoplasms
4
2024
2664
0.370
 Why?
Motivation
1
2017
600
0.370
 Why?
Social Support
2
2019
646
0.370
 Why?
Physicians
2
2019
955
0.360
 Why?
Survival Rate
7
2019
2090
0.360
 Why?
Bronchial Diseases
1
2012
38
0.360
 Why?
Patient Participation
1
2015
439
0.350
 Why?
Follow-Up Studies
9
2018
5423
0.340
 Why?
Quality Indicators, Health Care
1
2014
336
0.330
 Why?
Oxygen Consumption
3
2022
718
0.330
 Why?
Scleroderma, Systemic
4
2019
123
0.330
 Why?
Health Knowledge, Attitudes, Practice
2
2018
1419
0.320
 Why?
Multivariate Analysis
5
2017
1547
0.320
 Why?
Peptides, Cyclic
1
2012
273
0.320
 Why?
Health Status
5
2019
832
0.310
 Why?
Asthma
2
2020
1797
0.310
 Why?
Motor Activity
1
2014
718
0.300
 Why?
Endothelins
1
2010
61
0.300
 Why?
Protein Kinase Inhibitors
3
2021
981
0.300
 Why?
Hospitalization
3
2017
2460
0.300
 Why?
Cause of Death
6
2019
470
0.290
 Why?
Diagnosis, Differential
7
2019
1508
0.290
 Why?
Pulmonologists
2
2019
14
0.290
 Why?
Pulmonary Embolism
1
2011
241
0.280
 Why?
Proportional Hazards Models
4
2019
1327
0.280
 Why?
TRPP Cation Channels
1
2009
74
0.280
 Why?
Cohort Studies
8
2025
6013
0.280
 Why?
Amino Acyl-tRNA Synthetases
3
2016
32
0.280
 Why?
Endothelin-1
1
2010
181
0.280
 Why?
Polycystic Kidney Diseases
1
2009
71
0.270
 Why?
Registries
4
2025
2406
0.270
 Why?
Randomized Controlled Trials as Topic
6
2021
1747
0.270
 Why?
Sleep Apnea, Obstructive
1
2012
302
0.260
 Why?
Prospective Studies
9
2021
8057
0.250
 Why?
Sirolimus
2
2023
280
0.250
 Why?
Vascular Endothelial Growth Factor D
3
2023
13
0.250
 Why?
Bronchoalveolar Lavage Fluid
2
2025
638
0.240
 Why?
Biopsy
7
2016
1082
0.240
 Why?
Sex Distribution
3
2012
387
0.240
 Why?
Tumor Suppressor Proteins
1
2009
321
0.240
 Why?
Home Care Services
2
2020
284
0.240
 Why?
Exercise Therapy
3
2024
475
0.230
 Why?
Mortality
4
2019
378
0.230
 Why?
Prevalence
5
2018
2865
0.230
 Why?
Palliative Care
3
2019
1020
0.230
 Why?
Cost of Illness
3
2018
324
0.230
 Why?
Patient Advocacy
2
2024
73
0.230
 Why?
Lupus Erythematosus, Systemic
1
2008
238
0.220
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2025
122
0.220
 Why?
Quality Improvement
1
2014
1295
0.220
 Why?
Fibrosis
2
2024
559
0.200
 Why?
Minimal Clinically Important Difference
2
2021
31
0.200
 Why?
Thrombosis
1
2008
400
0.200
 Why?
Age Distribution
3
2019
403
0.200
 Why?
Time Factors
7
2019
7123
0.190
 Why?
Databases, Factual
3
2019
1490
0.190
 Why?
Evidence-Based Medicine
2
2020
740
0.190
 Why?
Delphi Technique
1
2024
332
0.180
 Why?
Respiratory Therapy
2
2019
25
0.180
 Why?
Sex Factors
6
2019
2105
0.180
 Why?
Environmental Exposure
2
2020
578
0.170
 Why?
Receptors, Lysophosphatidic Acid
1
2021
40
0.170
 Why?
Risk Factors
9
2026
10885
0.170
 Why?
Patient Care Management
1
2021
56
0.170
 Why?
Incidence
3
2018
2923
0.160
 Why?
Analysis of Variance
3
2015
1300
0.160
 Why?
Linear Models
3
2019
845
0.160
 Why?
Survival Analysis
3
2017
1374
0.160
 Why?
Interleukin-13
1
2021
146
0.150
 Why?
Pain Measurement
1
2022
561
0.150
 Why?
Antibodies, Antinuclear
4
2016
62
0.150
 Why?
Logistic Models
4
2019
2134
0.150
 Why?
Focus Groups
3
2016
569
0.150
 Why?
Walk Test
2
2017
81
0.150
 Why?
Sensitivity and Specificity
3
2015
1997
0.150
 Why?
Chi-Square Distribution
2
2011
527
0.140
 Why?
General Practitioners
1
2019
26
0.140
 Why?
Allied Health Personnel
1
2019
53
0.140
 Why?
Insurance Claim Review
1
2018
83
0.140
 Why?
Immunoglobulin A
1
2019
214
0.140
 Why?
Lipid Metabolism
1
2022
529
0.140
 Why?
Terminal Care
2
2019
283
0.130
 Why?
Oxidation-Reduction
1
2022
1067
0.130
 Why?
Accelerometry
2
2019
118
0.130
 Why?
Anxiety
3
2019
1118
0.130
 Why?
Attitude to Health
2
2014
430
0.130
 Why?
Physician Assistants
1
2019
101
0.130
 Why?
Weight-Bearing
1
2018
183
0.130
 Why?
Allergens
1
2020
386
0.120
 Why?
Cellular Senescence
1
2019
226
0.120
 Why?
Inflammation
2
2025
2878
0.120
 Why?
Cross-Sectional Studies
4
2019
5905
0.120
 Why?
Germany
1
2017
138
0.120
 Why?
Nurse Practitioners
1
2019
139
0.120
 Why?
Nurses
1
2019
171
0.120
 Why?
Common Variable Immunodeficiency
1
2016
26
0.120
 Why?
Host-Pathogen Interactions
1
2019
361
0.120
 Why?
Perception
1
2019
378
0.120
 Why?
Sulfonamides
2
2010
583
0.120
 Why?
Antihypertensive Agents
2
2010
519
0.120
 Why?
Tidal Volume
1
2016
109
0.120
 Why?
Granuloma
1
2016
97
0.120
 Why?
Cyclophosphamide
1
2016
270
0.110
 Why?
Medicare
2
2018
903
0.110
 Why?
Clinical Trials as Topic
3
2024
1061
0.110
 Why?
Muscle Strength
2
2015
332
0.110
 Why?
Health Policy
1
2018
400
0.110
 Why?
Physical Conditioning, Human
1
2015
38
0.110
 Why?
Nitric Oxide
1
2020
892
0.110
 Why?
Neuroendocrine Cells
1
2015
33
0.110
 Why?
Rituximab
1
2016
210
0.110
 Why?
Geographic Information Systems
1
2014
45
0.110
 Why?
Case-Control Studies
4
2019
3623
0.100
 Why?
Recovery of Function
1
2018
716
0.100
 Why?
Enzyme Inhibitors
2
2016
820
0.100
 Why?
Interviews as Topic
2
2016
910
0.100
 Why?
Controlled Clinical Trials as Topic
1
2013
27
0.100
 Why?
Societies, Medical
5
2020
899
0.100
 Why?
Sarcoidosis, Pulmonary
1
2015
98
0.100
 Why?
Sildenafil Citrate
1
2013
60
0.100
 Why?
Information Dissemination
1
2016
224
0.100
 Why?
Carbon Monoxide
3
2019
82
0.100
 Why?
Antifibrinolytic Agents
1
2014
64
0.100
 Why?
Sulfones
1
2013
127
0.100
 Why?
Phenotype
2
2018
3155
0.100
 Why?
Smoking
3
2019
1472
0.100
 Why?
Endpoint Determination
1
2013
85
0.100
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2013
43
0.100
 Why?
Predictive Value of Tests
3
2024
2121
0.090
 Why?
Purines
1
2013
187
0.090
 Why?
Patient Dropouts
1
2013
65
0.090
 Why?
Practice Guidelines as Topic
1
2020
1581
0.090
 Why?
Self Report
2
2019
870
0.090
 Why?
Antibiotics, Antineoplastic
1
2013
140
0.090
 Why?
Health Care Surveys
1
2014
536
0.090
 Why?
Pulmonary Gas Exchange
1
2012
116
0.090
 Why?
Histocompatibility Antigens Class II
1
2013
364
0.090
 Why?
Occupational Exposure
1
2016
355
0.090
 Why?
Vasodilator Agents
1
2013
330
0.090
 Why?
Adaptation, Psychological
1
2017
716
0.090
 Why?
Delivery of Health Care
1
2018
946
0.090
 Why?
Consensus
1
2013
477
0.090
 Why?
Dust
1
2012
92
0.090
 Why?
Minnesota
1
2012
168
0.090
 Why?
Piperazines
1
2013
375
0.080
 Why?
United Kingdom
1
2012
344
0.080
 Why?
Hydrogen-Ion Concentration
1
2012
531
0.080
 Why?
Fear
1
2014
368
0.080
 Why?
Clinical Competence
1
2019
1243
0.080
 Why?
Epidemiologic Methods
1
2010
91
0.080
 Why?
Anti-Infective Agents
1
2013
232
0.080
 Why?
Young Adult
5
2017
14219
0.080
 Why?
Health Surveys
1
2012
518
0.080
 Why?
Sickness Impact Profile
2
2009
62
0.080
 Why?
Salivary Glands, Minor
1
2009
10
0.070
 Why?
Pilot Projects
2
2015
1891
0.070
 Why?
Sjogren's Syndrome
1
2009
37
0.070
 Why?
Hyperplasia
2
2015
177
0.070
 Why?
International Cooperation
3
2015
197
0.070
 Why?
Risk
1
2011
919
0.070
 Why?
Scleroderma, Limited
1
2008
5
0.070
 Why?
Europe
3
2015
418
0.070
 Why?
Oximetry
1
2009
125
0.070
 Why?
Poisson Distribution
3
2016
78
0.070
 Why?
Radiography
2
2016
852
0.060
 Why?
Cardiac Catheterization
1
2011
558
0.060
 Why?
Wound Healing
1
2010
355
0.060
 Why?
Comorbidity
2
2017
1661
0.060
 Why?
Pericardium
1
2007
59
0.060
 Why?
Sleep Wake Disorders
1
2011
314
0.060
 Why?
Models, Statistical
1
2011
671
0.060
 Why?
Mass Screening
2
2026
1360
0.060
 Why?
Depression
2
2019
1546
0.060
 Why?
Clinical Trials, Phase III as Topic
2
2016
116
0.060
 Why?
Seasons
1
2008
538
0.060
 Why?
Medical Records
1
2006
192
0.060
 Why?
Regression Analysis
3
2016
1001
0.060
 Why?
Singapore
1
2024
27
0.050
 Why?
California
1
2005
471
0.050
 Why?
Echocardiography
1
2007
647
0.050
 Why?
Bronchoscopy
1
2025
227
0.050
 Why?
Dose-Response Relationship, Drug
2
2020
2028
0.050
 Why?
Acute Disease
1
2006
1036
0.050
 Why?
Data Interpretation, Statistical
2
2018
368
0.050
 Why?
National Institutes of Health (U.S.)
1
2024
147
0.050
 Why?
ROC Curve
1
2025
617
0.050
 Why?
Terminology as Topic
1
2005
257
0.050
 Why?
Lymphoid Tissue
1
2002
78
0.050
 Why?
Rheumatologists
1
2022
15
0.050
 Why?
Whole Genome Sequencing
1
2023
177
0.040
 Why?
Exome
1
2023
227
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2021
75
0.040
 Why?
Age Factors
3
2019
3342
0.040
 Why?
Lysophospholipids
1
2021
80
0.040
 Why?
Patient Care
1
2022
119
0.040
 Why?
Telomere
1
2024
287
0.040
 Why?
Patient Selection
1
2005
738
0.040
 Why?
Attitude
1
2022
259
0.040
 Why?
Total Lung Capacity
1
2019
29
0.040
 Why?
Genomics
1
2025
825
0.040
 Why?
Occupations
1
2019
50
0.040
 Why?
Pulmonary Surfactant-Associated Protein A
1
2019
30
0.040
 Why?
Adolescent
3
2017
22530
0.040
 Why?
Pulmonary Surfactant-Associated Protein C
1
2019
45
0.040
 Why?
Disease Models, Animal
1
2010
4560
0.040
 Why?
GTPase-Activating Proteins
1
2019
81
0.040
 Why?
Exoribonucleases
1
2019
43
0.040
 Why?
Blood Gas Analysis
1
2019
81
0.040
 Why?
ATP-Binding Cassette Transporters
1
2019
117
0.040
 Why?
Administration, Inhalation
1
2020
571
0.030
 Why?
Education
1
2018
104
0.030
 Why?
DNA Helicases
1
2019
136
0.030
 Why?
Telomere-Binding Proteins
1
2019
119
0.030
 Why?
Watchful Waiting
1
2018
90
0.030
 Why?
Administrative Claims, Healthcare
1
2017
28
0.030
 Why?
Forecasting
1
2019
390
0.030
 Why?
Physical Endurance
1
2019
279
0.030
 Why?
Telomerase
1
2019
246
0.030
 Why?
Mucin-5B
1
2019
234
0.030
 Why?
Hypersplenism
1
2016
9
0.030
 Why?
Spirometry
1
2017
233
0.030
 Why?
Leukopenia
1
2016
33
0.030
 Why?
Sequence Analysis, DNA
1
2019
777
0.030
 Why?
Banking, Personal
1
2016
2
0.030
 Why?
Algorithms
1
2024
1845
0.030
 Why?
Rheumatoid Factor
1
2017
178
0.030
 Why?
Health Care Sector
1
2016
26
0.030
 Why?
Creatine Kinase
1
2016
72
0.030
 Why?
High-Throughput Nucleotide Sequencing
1
2019
530
0.030
 Why?
Death Certificates
1
2016
32
0.030
 Why?
Social Participation
1
2016
29
0.030
 Why?
Health Services Needs and Demand
1
2017
280
0.030
 Why?
Arthritis
1
2016
96
0.030
 Why?
Biomarkers
2
2019
4295
0.030
 Why?
Commerce
1
2016
80
0.030
 Why?
Multiple Pulmonary Nodules
1
2015
23
0.030
 Why?
International Classification of Diseases
1
2016
150
0.030
 Why?
Metals
1
2016
136
0.030
 Why?
Anthropometry
1
2015
206
0.030
 Why?
Promoter Regions, Genetic
1
2019
1246
0.030
 Why?
Physical Examination
1
2016
243
0.030
 Why?
Pandemics
1
2023
1707
0.030
 Why?
Genetic Variation
1
2019
972
0.030
 Why?
Disease-Free Survival
1
2016
767
0.030
 Why?
Alberta
1
2013
25
0.030
 Why?
Bronchiolitis
1
2015
87
0.030
 Why?
Mortality, Premature
1
2013
15
0.020
 Why?
Teaching
1
2016
237
0.020
 Why?
Adrenal Cortex Hormones
1
2016
484
0.020
 Why?
Odds Ratio
1
2016
1082
0.020
 Why?
Counseling
1
2016
400
0.020
 Why?
RNA
1
2019
910
0.020
 Why?
Drug Therapy, Combination
1
2016
1044
0.020
 Why?
Genome-Wide Association Study
1
2019
1407
0.020
 Why?
Congresses as Topic
1
2013
223
0.020
 Why?
Administration, Oral
1
2014
866
0.020
 Why?
Antigens, Human Platelet
1
2011
10
0.020
 Why?
Latin America
1
2011
96
0.020
 Why?
Japan
1
2011
149
0.020
 Why?
Genetic Predisposition to Disease
1
2019
2378
0.020
 Why?
Alanine-tRNA Ligase
1
2009
4
0.020
 Why?
Threonine-tRNA Ligase
1
2009
5
0.020
 Why?
Psychiatric Status Rating Scales
1
2011
531
0.020
 Why?
DNA Topoisomerases, Type I
1
2008
14
0.020
 Why?
Syndrome
1
2009
381
0.020
 Why?
Cell Proliferation
1
2015
2507
0.020
 Why?
Animals
1
2010
38030
0.020
 Why?
Lymphocytes
1
2009
376
0.020
 Why?
Pulmonary Wedge Pressure
1
2007
66
0.020
 Why?
Body Mass Index
1
2015
2445
0.020
 Why?
Risk Assessment
1
2015
3747
0.010
 Why?
Muscle, Skeletal
1
2015
1789
0.010
 Why?
Nuclear Proteins
1
2008
740
0.010
 Why?
Child
1
2002
22707
0.010
 Why?
Pneumonia
1
2008
636
0.010
 Why?
Swigris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (372) concept(s)
_
Co-Authors Expand Description
See all (38) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)